Date | Operating Cash Flow | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities | Dividends Paid |
---|
CEO | Mr. Marcus Wolfinger |
IPO Date | June 16, 2000 |
Location | Germany |
Headquarters | Gewerbestrasse 37 |
Employees | 1,462 |
Sector | Health Care |
Industries |
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Past 5 years
USD 50.29
USD 22.41
USD 48.95
USD 158.71
USD 23.50
StockViz Staff
January 15, 2025
Any question? Send us an email